← Back
$GPCR All transactions

Structure Therapeutics Inc.

▼ SELL

$ Value

$46K

Shares

552

Price

$84

Filed

Jan 20

Insider

Name

FMR LLC

Title

CIK

0000315066

Roles

10% Owner Other

Transaction Details

Transaction Date

2026-01-15

Code

S

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

4,123

Footnotes

Reported securities are represented by American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. | The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $82.00 to $82.37. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information | The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $83.00 to $83.84. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information | The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $84.00 to $84.64. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information | The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $85.02 to $85.06. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information

Filing Info

Accession No.

0001193125-26-016062

Form Type

4

Issuer CIK

0001888886

FMR LLC's History

Date Ticker Type Value
2026-04-14 GPCR $75K
2026-04-14 GPCR $886K
2026-01-15 GPCR $38K
2026-01-15 GPCR $28K
2026-01-15 GPCR $46K
2026-01-15 GPCR $2K
2026-01-15 GPCR $450K
2026-01-15 GPCR $323K
2026-01-15 GPCR $547K
2026-01-15 GPCR $20K

Other Insiders at GPCR (90d)

Insider Bought Sold Last
FMR LLC $961K 2026-04-14
Stevens Raymond C
CHIEF EXECUTIVE OFFICER
2026-03-19
Lang Matthew
COO & GC
2026-04-15
Hall Ashley
Chief Development Officer
2026-03-19
Yoon Jun
CHIEF FINANCIAL OFFICER
2026-03-19
Lin Xichen
CHIEF SCIENTIFIC OFFICER
2026-03-19
Ma Yingli
CHIEF TECHNOLOGY OFFICER
2026-03-19
Coll Crespo Blas
CHIEF MEDICAL OFFICER
2026-03-19